Open | - |
Close | - |
Volume / Avg. | 1.000 / 292.513K |
Day Range | - - - |
52 Wk Range | 0.567 - 2.530 |
Market Cap | $84.754M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | % |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioLine Rx (NASDAQ: BLRX) through any online brokerage.
Other companies in BioLine Rx’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Vaxxinity (NASDAQ:VAXX), CARISMA Therapeutics (NASDAQ:CARM), Immuneering (NASDAQ:IMRX) and Eagle Pharmaceuticals (NASDAQ:EGRX).
The latest price target for BioLine Rx (NASDAQ: BLRX) was reported by HC Wainwright & Co. on Thursday, February 29, 2024. The analyst firm set a price target for 21.00 expecting BLRX to rise to within 12 months (a possible 1694.87% upside). 5 analyst firms have reported ratings in the last year.
The stock price for BioLine Rx (NASDAQ: BLRX) is $1.17 last updated March 18, 2024 at 6:14 PM EDT.
There are no upcoming dividends for BioLine Rx.
BioLine Rx’s Q1 earnings are confirmed for Wednesday, May 22, 2024.
There is no upcoming split for BioLine Rx.
BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.